RGCC Metastat

Choose The Powerful Tool In The Fight Against Cancer

RGCC Metastat test is a specialized diagnostic tool that identifies specific blood-borne markers that can determine the likelihood and possible location of the development of a secondary tumour. If the patients’ cancer has the probability of metastasizing, it tends to express specific genes and proteins according to the organ that is likely to metastasize.

Sample Type
Whole peripheral blood sample
Sample Size
10-15ml blood
All Types
Turnaround Time
21 days

How it works?

The test provides comprehensive information on tumor cells using blood-borne markers and timely assessment of secondary cancer or tumor development and paves the way for more tailored and effective cancer treatment options.

How it is done?

Initially, the test isolates White Blood Cells (WBC) and mRNA, followed by the synthesis of cDNA from the mRNA strands.
Specific gene markers are then quantified using Real-Time PCR assay, allowing for precise measurement.
Flow cytometry is utilized to identify these specific markers within the genetic material.
Finally, the data obtained from both assays undergo comprehensive analysis and comparison with normal samples, providing valuable information about any abnormalities present.

Why choose RGCC Metastat?

RGCC Metastat is a valuable tool suitable for all patients who have received a confirmed cancer diagnosis. Linking metastasis in a patient to the primary tumour gives us a better understanding of the progression of the disease and the treatment options.

It delivers an accurate and timely assessment of secondary cancer or tumor development. The test determines the extent of cancer spread to the lungs, brain, liver, or bones. It arms both doctors and cancer patients with the information needed to take proactive measures and make informed decisions.

Which cancers are tested?

Metastat test suitable for all patients who have confirmed cancer diagnosis can accurately predict the secondary cancer that may develop in the lungs, liver, brain or other parts of the body.

The test applies to all types of cancers and not just limited to the following.

Head & Neck Cancer
Liver Cancer
Kidney Cancer
Prostate Cancer
Pancreatic Cancer
Colon Cancer
Lung Cancer
Gastric Cancer
Colorectal Cancer
Bladder Cancer
Breast Cancer


Book an appointment

The first step towards personalized cancer care is scheduling an appointment with us.


30 minutes value packed consultation

Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.


Finding the right tests

We guide you through the process of selecting the most effective tests for your specific cancer.


Personalized results

We deliver precise results that guide treatment decisions and enhance outcomes.

Why clinicians prefer RGCC Metastat than other similar tests?

Dr. John Soo

“I feel that RGCC’s Metastat test is a game-changer in identifying secondary tumor development and potential locations. Its precision enables early intervention, improving patient outcomes and quality of life. A vital tool in the fight against cancer.”

Request a Second Opinion

Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.

Useful information

RGCC Metastat is usually used when you see signs of recurrence or relapse in follow-up tests like Oncocount, Oncotrace, or Oncotrail.

Start your personalized cancer journey with us!

Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.

    Frequently Asked Questions

    • Can tests be conducted during ongoing treatment?

      Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.

    • What happens to my blood sample post-testing?

      Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells.

    • Is a blood sample sufficient?

      Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.

    • Can the origin of a tumor be determined by the tests?

      Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.

    • What tests are effective in identifying the emergence of secondary tumors?

      RGCC Metastat is an effective test for identifying secondary tumors development and its potential location. It helps detect secondary tumors through analyzing Circulating Tumor Cells (CTCs) in the bloodstream. The test provides valuable insights into disease progression and metastasis.

    • How do tests personalize cancer treatment?

      Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.

    • What are CTCs and CSCs?

      Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.

    • Do tests reveal drug response and sensitivity to immunotherapy?

      Tests like ChemoSNiP and CAMBISeq provide information on the body’s response to the drugs and sensitivity to immunotherapy.

    Catch cancer progression early with RGCC Metastat

    Want to stay ahead of your cancer progression? Gain comprehensive insights into your tumor cells with RGCC metastat test. Timely assessment of secondary cancer or tumor development enables personalized and effective treatment options. Empower yourself with tailored solutions for better outcomes in your cancer journey.